Clinical Trial Update: Surgery Plus Reduced Target Chemoradiotherapy vs Surgery Plus Reduced Dose Chemoradiotherapy for Newly Diagnosed Operable Nasopharyngeal Carcinoma. [NA]

View source ↗

Summary

This clinical trial compares two chemoradiotherapy regimens combined with surgery for newly diagnosed operable nasopharyngeal carcinoma. The study is currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Snippet

Sponsor: Ming-Yuan Chen | Conditions: Nasopharyngeal Carcinoma | NA | Status: RECRUITING